Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel peptide inhibitors of angiotensin-converting enzyme 2.
Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, Parry T, Kent R, Enright J, Wu QL, Conley G, DeOliveira D, Morganelli L, Ducar M, Wescott CR, Ladner RC. Huang L, et al. Among authors: devlin m. J Biol Chem. 2003 May 2;278(18):15532-40. doi: 10.1074/jbc.M212934200. Epub 2003 Feb 26. J Biol Chem. 2003. PMID: 12606557 Free article.
Discovery of high-affinity peptide binders to BLyS by phage display.
Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ. Fleming TJ, et al. Among authors: devlin m. J Mol Recognit. 2005 Jan-Feb;18(1):94-102. doi: 10.1002/jmr.722. J Mol Recognit. 2005. PMID: 15382264
A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.
Shrivastava A, von Wronski MA, Sato AK, Dransfield DT, Sexton D, Bogdan N, Pillai R, Nanjappan P, Song B, Marinelli E, DeOliveira D, Luneau C, Devlin M, Muruganandam A, Abujoub A, Connelly G, Wu QL, Conley G, Chang Q, Tweedle MF, Ladner RC, Swenson RE, Nunn AD. Shrivastava A, et al. Among authors: devlin m. Protein Eng Des Sel. 2005 Sep;18(9):417-24. doi: 10.1093/protein/gzi049. Epub 2005 Aug 8. Protein Eng Des Sel. 2005. PMID: 16087652
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, Rem L, Frans N, Daukandt M, Pieters H, van Hegelsom R, Neer NC, Nastri HG, Rondon IJ, Leeds JA, Hufton SE, Huang L, Kashin I, Devlin M, Kuang G, Steukers M, Viswanathan M, Nixon AE, Sexton DJ, Hoogenboom HR, Ladner RC. Hoet RM, et al. Among authors: devlin m. Nat Biotechnol. 2005 Mar;23(3):344-8. doi: 10.1038/nbt1067. Epub 2005 Feb 20. Nat Biotechnol. 2005. PMID: 15723048
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.
Hanna D, Merrick S, Ghose A, Devlin MJ, Yang DD, Phillips E, Okines A, Chopra N, Papadimatraki E, Ross K, Macpherson I, Boh ZY, Michie CO, Swampillai A, Gupta S, Robinson T, Germain L, Twelves C, Atkinson C, Konstantis A, Riddle P, Cresti N, Naik JD, Borley A, Guppy A, Schmid P, Phillips M. Hanna D, et al. Among authors: devlin mj. Br J Cancer. 2024 Apr 24. doi: 10.1038/s41416-024-02685-9. Online ahead of print. Br J Cancer. 2024. PMID: 38658782
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM; STOP-MSU Trial Investigators. Yassi N, et al. Among authors: devlin m. Lancet Neurol. 2024 Jun;23(6):577-587. doi: 10.1016/S1474-4422(24)00128-5. Epub 2024 Apr 20. Lancet Neurol. 2024. PMID: 38648814 Clinical Trial.
518 results